CAS Insights^TM

Different types of antisense oligonucleotide therapies, such as exosomes and nanoparticles, offering new hope in genetic medicine.

Learn how emerging trends in AI are impacting CBRNE threat detection and mitigation.

Unlock the potential of nanotechnology. Explore breakthroughs and challenges in energy, biomedicine, and more in our executive summary.

This biomaterials Insights Report explores eight key areas transforming healthcare with self-healing implants, targeted drug delivery, and more.

David Saari, Ph.D., shares his thoughts on blending science, law, and technology in IP, highlighting the competitive edge of multidisciplinary expertise.

Uncover the science behind sweeteners, their health impacts, R&D trends, and investment data.

While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.

We speak with Mauro Mileni, Ph.D., and Chris Roth, Ph.D., about how their company is leveraging specific technology to fill an innovative drug pipeline.

Carbon nanotubes (CNTs) hold immense promise for batteries, composites, sensors, and more. Discover emerging trends on overcoming challenges and cutting edge applications.

Biomarkers could help doctors catch cancer earlier, cure it more frequently, and perform treatments with fewer risks.

Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.

Pocket-sized nuclear batteries are here. Discover their potential and limitations, from powering wearables to tackling radioactive waste.

Recycling semiconductors was once a far-off dream. However, new research and technology shows that this could become reality.

Explore the science behind sweeteners, their health impact, and emerging alternatives.

Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.

See key insights on emerging RNA IP trends and possibilities for future innovations in this executive summary.

As antimicrobial resistance becomes a larger problem, new approaches to battling infections are emerging.

The landscape of exosomes has become highly competitive. See all the recent investments, innovations, and commercial opportunities.

Experts from Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS discuss major research trends in 2024.

As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.

CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.

Discover how AI in the food industry is transforming production, innovation, and sustainability. Learn how AI can help you create smarter and more efficient food solutions.

Immunotherapy is advancing with new approaches like CAR-T cell therapy, antibody-drug conjugates, and even checkpoint inhibitors.

AI is redefining natural product drug discovery by unlocking diverse candidates from plants, microbes, and more.

Antimicrobial-resistant infections are a global public health crisis. New solutions like AI, alternative therapeutics, and innovations in materials offer a way to fight back.